Monday, 16 July 2012

TPG agrees to buy generic drugmaker Par for $1.9 billion



(Reuters) - Private equity firm TPG said on Monday it would acquire U.S.-based Par Pharmaceutical Cos Inc for $1.9 billion in the latest acquisition in the generic drug industry.





via Reuters: Health News Read More Here..

No comments:

Post a Comment